Amazing and very cool! A couple of questions, if you can share at this time, since this resonates with my interests.

- Which patient/donor cell type are these immune organoids derived from?

- Are the organoids made with induced pluripotent stem cell technology?

- What is part of the workup post treatment, e.g. histology, NGS? If NGS, what kind (WGS, WES, RNASeq) and technologies (Illumina, PacBio, ONT)?

- Are you looking for mutations from the drug and vaccine treatment (e.g. comet assay, Duplex-Seq)?